First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
ppublish
Résumé
Cardiorenal syndrome worsens outcome in patients with decompensated chronic heart failure, and complicates recompensation by medical therapy. Mechanical circulatory support has the potential to improve renal function, and likely mitigates diuretic resistance in patients with severe cardiorenal syndrome. The Reitan catheter pump (RCP) is a novel temporary percutaneous circulatory support system for reducing cardiac afterload and increasing renal preload. Here, we report on the first-in-man use of the 10F-version of the RCP device, which was associated with favorable effects on hemodynamics and diuresis. Further investigation to evaluate safety and efficacy of this promising approach is warranted.
Identifiants
pubmed: 35649225
doi: 10.1097/MAT.0000000000001498
pii: 00002480-202206000-00022
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e99-e101Informations de copyright
Copyright © ASAIO 2021.
Références
Keeble TR, Karamasis GV, Rothman MT, et al.: Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP). Int J Cardiol. 275: 53–58, 2019.
Regamey J, Barras N, Rusca M, Hullin R: A role for the Reitan catheter pump for percutaneous cardiac circulatory support of patients presenting acute congestive heart failure with low output and renal dysfunction? Future Cardiol. 16: 159–164, 2020.
German Registry for Clinical Studies. Available at: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00013205 . Accessed March 12, 2020.
Chahal RS, Chukwu CA, Kalra PR, Kalra PA: Heart failure and acute renal dysfunction in the cardiorenal syndrome. Clin Med (Lond). 20: 146–150, 2020.
Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S: Heart failure and kidney dysfunction: Epidemiology, mechanisms and management. Nat Rev Nephrol. 12: 610–623, 2016.
Virani SS, Alonso A, Benjamin EJ, et al.: Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation. 141: e139–e596, 2020.
Ricklefs M, Heimeshoff J, Hanke JS, et al. The influence of less invasive ventricular assist device implantation on renal function. J Thorac Dis. 10(suppl 15): S1737–S1742, 2018.
König T, Hanke JS, Dogan G, et al.: Advanced preconditioning: Impella 5.5 support for decompensated heart failure before left ventricular assist device surgery [published online ahead of print August 22, 2020]. Cardiovasc Revasc Med. doi: 10.1016/j.carrev.2020.08.022.
doi: 10.1016/j.carrev.2020.08.022
Dekker A, Reesink K, van der Veen E, et al.: Efficacy of a new intraaortic propeller pump vs the intraaortic balloon pump: An animal study. Chest. 123: 2089–2095, 2003.
Reitan O, Steen S, Ohlin H: Hemodynamic effects of a new percutaneous circulatory support device in a left ventricular failure model. ASAIO J. 49: 731–736, 2003.
Reitan O, Sternby J, Ohlin H: Hydrodynamic properties of a new percutaneous intra-aortic axial flow pump. ASAIO J. 46: 323–329, 2000.
Smith EJ, Reitan O, Keeble T, Dixon K, Rothman MT: A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv. 73: 859–865, 2009.